
Absci Corporation Common Stock
ABSI Real Time Price USDRecent trades of ABSI by members of U.S. Congress
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
---|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Recently reported changes by institutional investors
Quarterly net insider trading by ABSI's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
ABSI Revenue by Segment or Geography
New patents grants
-
Patent Title: Cytoplasmic expression system Dec. 03, 2024
-
Patent Title: Cancer associated antibody compositions and methods of use Nov. 05, 2024
-
Patent Title: C-peptides and proinsulin polypeptides comprising the same Feb. 21, 2023
-
Patent Title: Host cells for use in an inducible coexpression system Sep. 20, 2022
-
Patent Title: Vectors for use in an inducible coexpression system Jun. 28, 2022
-
Patent Title: Coordinated coexpression of thrombin Dec. 17, 2019
-
Patent Title: Inducible coexpression system Apr. 11, 2017
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to ABSI
Number of mentions of ABSI in WallStreetBets Daily Discussion
Recent picks made for ABSI stock on CNBC
ETFs with the largest estimated holdings in ABSI
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
---|
- Is $ABSI stock a Buy, Sell, or Hold?
- What is the price target for $ABSI stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
Shareholder
|
Shares Held
|
---|
- Who owns $ABSI stock?
- Who owns the most shares of $ABSI stock?
- What funds own $ABSI stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view ABSI Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.